Waddington Simon 4
Accession 0001209191-05-033317
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:22 PM ET
Size
81.8 KB
Accession
0001209191-05-033317
Insider Transaction Report
- Conversion
Common Stock Warrant
2005-06-21+71,463→ 71,463 total(indirect: Polytechnos Medical Devices Ltd.)Exercise: $7.52→ Common Stock (71,463 underlying) - Conversion
Common Stock
2005-06-21+2,329→ 2,329 total(indirect: Polytechnos Partners & Team GMBH) - Exercise of In-Money
Common Stock Warrant
2005-06-21−71,463→ 0 total(indirect: Polytechnos Medical Devices Ltd.)Exercise: $7.52→ Common Stock (71,463 underlying) - Conversion
Common Stock Warrant
2005-06-21+20,660→ 20,660 total(indirect: Polytechnos Venture Fund II LP)Exercise: $7.52→ Common Stock (20,660 underlying) - Exercise of In-Money
Common Stock
2005-06-21+143→ 2,472 total(indirect: Polytechnos Partners & Team GMBH) - Conversion
Series D-3 Preferred Stock
2005-06-21−30,776→ 0 total(indirect: Polytechnos Venture Fund II LP)→ Common Stock (30,776 underlying) - Exercise of In-Money
Common Stock Warrant
2005-06-21−333→ 0 total(indirect: Global Venture Advisors GMBH)Exercise: $7.52→ Common Stock (333 underlying) - Conversion
Serries D Preferred Warrant
2005-06-21−20,660→ 0 total(indirect: Polytechnos Venture Fund II LP)Exercise: $7.52→ Series D Preferred Stock (20,660 underlying) - Conversion
Common Stock
2005-06-21+291,404→ 291,404 total(indirect: Polytechnos Venture Fund II LP) - Conversion
Series D Preferred Stock
2005-06-21−153,885→ 0 total(indirect: Polytechnos Venture Fund II LP)→ Common Stock (153,885 underlying) - Conversion
Series D Preferred Stock
2005-06-21−38,332→ 0 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)→ Common Stock (38,332 underlying) - Conversion
Series D-3 Preferred Stock
2005-06-21−7,666→ 0 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)→ Common Stock (7,666 underlying) - Conversion
Series D Preferred Warrant
2005-06-21−71,463→ 0 total(indirect: Polytechnos Medical Devices Ltd.)Exercise: $7.52→ Series D Preferred Stock (71,463 underlying) - Conversion
Series D Preferred Warrant
2005-06-21−260→ 0 total(indirect: Polytechnos Partners & Team GMBH)Exercise: $7.52→ Series D Preferred Stock (260 underlying) - Conversion
Common Stock Warrant
2005-06-21+260→ 260 total(indirect: Polytechnos Partners & Team GMBH)Exercise: $7.52→ Common Stock (260 underlying) - Conversion
Series D-3 Preferred Stock
2005-06-21−666→ 0 total(indirect: Global Venture Advisors GMBH)→ Common Stock (666 underlying) - Conversion
Series E Preferred Stock
2005-06-21−26,588→ 0 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)→ Common Stock (26,588 underlying) - Conversion
Common Stock
2005-06-21+532,268→ 532,268 total(indirect: Polytechnos Medical Devices Ltd.) - Exercise of In-Money
Common Stock
2005-06-21+2,844→ 75,430 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG) - Conversion
Common Stock
2005-06-21+72,586→ 72,586 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG) - Conversion
Common Stock
2005-06-21+666→ 666 total(indirect: Global Venture Advisors GMBH) - Exercise of In-Money
Common Stock
2005-06-21+106→ 772 total(indirect: Global Venture Advisors GMBH) - Exercise of In-Money
Common Stock
2005-06-21+11,420→ 302,824 total(indirect: Polytechnos Venture Fund II LP) - Exercise of In-Money
Common Stock Warrant
2005-06-21−20,660→ 0 total(indirect: Polytechnos Venture Fund II LP)Exercise: $7.52→ Common Stock (20,660 underlying) - Exercise of In-Money
Common Stock Warrant
2005-06-21−194→ 0 total(indirect: Polytechnos Partners & Team GMBH)Exercise: $7.52→ Common Stock (194 underlying) - Exercise of In-Money
Common Stock
2005-06-21+22,641→ 554,909 total(indirect: Polytechnos Medical Devices Ltd.) - Conversion
Series D Preferred Stock
2005-06-21−532,268→ 0 total(indirect: Polytechnos Medical Devices Ltd.)→ Common Stock (532,268 underlying) - Conversion
Series D-3 Preferred Stock
2005-06-21−388→ 0 total(indirect: Polytechnos Partners & Team GMBH)→ Common Stock (388 underlying) - Conversion
Series D Preferred Warrant
2005-06-21−5,146→ 0 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)Exercise: $7.52→ Series D Preferred Stock (5,146 underlying) - Conversion
Series D Preferred Stock
2005-06-21−1,941→ 0 total(indirect: Polytechnos Partners & Team GMBH)→ Common Stock (1,941 underlying) - Exercise of In-Money
Common Stock Warrant
2005-06-21−5,146→ 0 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)Exercise: $7.52→ Common Stock (5,146 underlying) - Conversion
Series E Preferred Stock
2005-06-21−106,743→ 0 total(indirect: Polytechnos Venture Fund II LP)→ Common Stock (106,743 underlying) - Exercise of In-Money
Common Stock Warrant
2005-06-21−260→ 0 total(indirect: Polytechnos Partners & Team GMBH)Exercise: $7.52→ Common Stock (260 underlying) - Exercise of In-Money
Common Stock Warrant
2005-06-21−15,388→ 0 total(indirect: Polytechnos Venture Fund II LP)Exercise: $7.52→ Common Stock (15,388 underlying) - Conversion
Common Stock Warrant
2005-06-21+5,146→ 5,146 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)Exercise: $7.52→ Common Stock (5,146 underlying) - Exercise of In-Money
Common Stock Warrant
2005-06-21−3,833→ 0 total(indirect: Polytechnos Venture Fund II GMBH & Co. KG)Exercise: $7.52→ Common Stock (3,833 underlying)
Footnotes (8)
- [F1]Converts on a 1 to 1 basis.
- [F2]The shares were acquired by the net exercise of warrants.
- [F3]N/A
- [F4]The Common Warrants were converted and exercised for Common Stock at the closing of the initial public offering.
- [F5]The warrants were net exercised.
- [F6]Immediately Exerciseable
- [F7]Five years from the date of issuance or at the close of initial public offering.
- [F8]The Series D Preferred Warrants were converted and exercised for Common Stock at the closing of the initial public offering.
Documents
Issuer
MICRUS ENDOVASCULAR CORP
CIK 0001028318
Related Parties
1- filerCIK 0001325627
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 9:22 PM ET
- Size
- 81.8 KB